Stone, J. A., McCrea, J. B., Witter, R., Zajic, S., & Stoch, S. A. (2019). Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis. Br J Clin Pharmacol.
Style de citation ChicagoStone, Julie A., Jacqueline B. McCrea, Rose Witter, Stefan Zajic, et S. Aubrey Stoch. "Clinical and Translational Pharmacology of the Cathepsin K Inhibitor Odanacatib Studied for Osteoporosis." Br J Clin Pharmacol 2019.
Style de citation MLAStone, Julie A., et al. "Clinical and Translational Pharmacology of the Cathepsin K Inhibitor Odanacatib Studied for Osteoporosis." Br J Clin Pharmacol 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.